Skip to content

What are the inhibitors and opportunities for smartwatch implementation in diabetes patients

What are the inhibitors and opportunities for smartwatch implementation in diabetes patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00027800
Enrollment
200
Registered
2022-03-14
Start date
2022-03-15
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E10 E11

Interventions

Group 1: Only observation via a questionnaire

Sponsors

Fliedner Fachhochschule
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Access to Internet-enabled devices Diabetes type 1/2 Sufficient knowledge of German

Exclusion criteria

Exclusion criteria: No consent in the questionnaire younger than 18 years

Design outcomes

Primary

MeasureTime frame
The goal will be to explain the inhibitions and opportunities in the use of smartwatches in diabetes mellitus patients

Secondary

MeasureTime frame
better therapy options

Countries

Germany

Contacts

Public ContactLukas Oberwinster

Fliedner Fachhochschule

l.oberwinster@studium.fliedner-fh.de015730121962

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026